Literature DB >> 1403211

Ambulatory opiate detoxification and primary care: a role for the primary care physician.

P G O'Connor1, M E Waugh, R S Schottenfeld, I A Diakogiannis, B J Rounsaville.   

Abstract

To determine the feasibility of primary care-based ambulatory opiate detoxification (AOD) and an optimal regimen, the authors conducted a pilot study of AOD in a medical clinic comparing two regimens: clonidine and clonidine plus naltrexone. Sixty-two opiate addicts who had been referred for AOD had the following features: mean age was 34 years, 75% were male, 74% used cocaine, and 64% shared needles. Initially, 40 patients selected clonidine, 22 clonidine/naltrexone. The groups (clonidine and clonidine/naltrexone) were similar in baseline features, including: craving scores (44/100 vs. 42/100) and withdrawal scores (20/72 vs. 17/72). Overall, 61% (38/62) of initial AODs were successful, including 43% (17/40) of those using clonidine and 95% (21/22) of those using clonidine/naltrexone (p less than 0.0001). Of 45 patients who ultimately completed AOD, 78% (35/45) remained in treatment for at least one month.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403211     DOI: 10.1007/bf02599459

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  8 in total

1.  Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers.

Authors:  E Vining; T R Kosten; H D Kleber
Journal:  Br J Addict       Date:  1988-05

2.  Rapid opiate detoxification with clonidine and naloxone.

Authors:  C E Riordan; H D Kleber
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

3.  Prescribing narcotics to habitual and addicted narcotic users. Medical and legal guidelines in California and some other Western states.

Authors:  F S Tennant; G F Uelmen
Journal:  West J Med       Date:  1980-12

4.  Clonidine for opiate detoxification: outpatient clinical trials.

Authors:  A M Washton; R B Resnick
Journal:  Am J Psychiatry       Date:  1980-09       Impact factor: 18.112

5.  Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

Authors:  H D Kleber; M Topazian; J Gaspari; C E Riordan; T Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  1987       Impact factor: 3.829

6.  Clonidine in morphine withdrawal. Differential effects on signs and symptoms.

Authors:  D R Jasinski; R E Johnson; T R Kocher
Journal:  Arch Gen Psychiatry       Date:  1985-11

7.  The combined use of clonidine and naltrexone as a rapid, safe, and effective treatment of abrupt withdrawal from methadone.

Authors:  D S Charney; G R Heninger; H D Kleber
Journal:  Am J Psychiatry       Date:  1986-07       Impact factor: 18.112

8.  The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.

Authors:  D S Charney; D E Sternberg; H D Kleber; G R Heninger; D E Redmond
Journal:  Arch Gen Psychiatry       Date:  1981-11
  8 in total
  4 in total

1.  Legality of methadone treatment.

Authors:  N P Peyser
Journal:  J Gen Intern Med       Date:  1993-05       Impact factor: 5.128

2.  Primary care-based ambulatory opioid detoxification: the results of a clinical trial.

Authors:  P G O'Connor; M E Waugh; K M Carroll; B J Rounsaville; I A Diagkogiannis; R S Schottenfeld
Journal:  J Gen Intern Med       Date:  1995-05       Impact factor: 5.128

Review 3.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

Review 4.  Pharmacological therapies for management of opium withdrawal.

Authors:  Afarin Rahimi-Movaghar; Jaleh Gholami; Laura Amato; Leila Hoseinie; Reza Yousefi-Nooraie; Masoumeh Amin-Esmaeili
Journal:  Cochrane Database Syst Rev       Date:  2018-06-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.